Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 09:35
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
PCCOSMA's 26.05% gross margin accelerated to, up from 6.76%.
The company's .76% marginal operating leverage also accelerated, up from .19%. Additionally, PCCOSMA's .4% revenue growth year-over-year accelerated, up from .8%. However, the company's to . Furthermore, PCCOSMA's to .55 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 26.05 % | 6.76 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.76 % | 5.19 | ▲ |
| REVENUE_GROWTH_YOY | 23.4 % | 11.8 | ▲ |
| PRICE_CHANGE_PERCENT | -1.383 % | — | - |
| DAILY_VOLUME | 469 shares | 2,518 | ▼ |
| CLOSE_PRICE | 467 INR | 473.55 | ▼ |
Cite this
Source: Samhati evidence synthesis for PCCOSMA (2026-10-20). Observation: PCCOSMA's 26.05% gross margin accelerated to, up from 6.76%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/pccosma
Filing step-changes